Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets ...

A jab given to patients to battle RSV through the NHS could potentially cause a disabling condition known as Guillain-Barré ...

GlaxoSmithKline has found a replacement for head of vaccines R&D Emmanuel Hanon, who left the company for a US biotech earlier this year, hiring Phil Dormitzer from ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

Berenberg Bank analyst Kerry Holford maintained a Hold rating on FRESNILLO (FNLPF – Research Report) yesterday and set a price target of ...

Select listed pharma player including Pfizer, Novartis India, AstraZeneca Pharma and GSK Pharma shall be the beneficiaries of ...

GlaxoSmithKline places its shingles vaccine Shingrix among its top prospects, with peak sales potential of almost $6 billion. Now, Pfizer and BioNTech are joining forces to try to grab a slice of ...

In a report released yesterday, Kerry Holford from Berenberg Bank maintained a Buy rating on Endeavour Mining (EDV – Research Report), with a ...

BURLINGAME, CA, UNITED STATES, January 17, 2025 /EINPresswire / -- The Drug Discovery Market Report is the result of extensive research and analysis conducted by our team of experienced market ...

Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Fort Lauderdale-based ...